ScandiPharm.com
Title
Axcan Pharma Inc. - Home Page
Description
Excerpted from the website:
- Axcan Pharma Initiates MAX-002 Phase III Clinical Trial to Evaluate the Efficacy and Safety of a High-Concentration 1 Gram Mesalamine Suppository
Languages
English
Address
- 22 Inverness Center Pkwy Ste 310
- Birmingham AL 35242 US
Contact
- Axcan Scandipharm, Inc.
-
- +1 205 991 0870 x252, Fax: +1 205 991 9547
Logos
